跳至主要内容
临床试验/NCT06365229
NCT06365229已完成不适用

Percutaneous Unilateral Biportal Endoscopy Versus Uniportal Endoscopy for Lumbar Spinal Stenosis: a Single-center, Prospective, Non-randomized Cohort Trial Protocol

Beijing Friendship Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Oswestry Disability Index (ODI)

研究概览

简要总结

A prospective study aimed to compare the efficacy and safety of Unilateral biportal endoscopic (UBE) technique and uniportal endoscopic (UE) technique for treating patients with lumbar spinal stenosis (LSS).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age range: 50-80 years
  • Diagnosed with LSS of 1-2 response levels
  • The predominant manifestation is neurogenic intermittent claudication, and conservative treatment has been ineffective for at least 3 months
  • Degenerative lumbar spondylolisthesis of less than I degree or without spine instability
  • Patients agree to participate in the study and are willing to complete the follow-up

排除标准

  • Isthmic lumbar spondylolisthesis or degenerative lumbar spondylolisthesis of greater than I degree
  • Instability at the response level
  • Prior surgical history at the response level
  • Scoliosis with Cobb angle >20 degrees
  • Other conditions affecting the lumbar spine (infection, tumor, fracture, neurological diseases, and others)
  • Patients with medical disorders who are unable to tolerate surgery

结局指标

主要结局

Oswestry Disability Index (ODI)

时间窗: From enrollment to the end of follow-up at 1 year

0-100%, the higher the score, the more severe the lumbar spine dysfunction

次要结局

  • Operation time(Immediately after the surgery)
  • Erythrocyte sedimentation rate (ESR)(From enrollment to the follow-up at 2 weeks)
  • VAS (visual analogue scale) for leg pain(From enrollment to the end of follow-up at 1 year)
  • Stenosis grade(Baseline, pre-surgery)
  • Surgical complication(From enrollment to the end of follow-up at 1 year)
  • Blood loss(Immediately after the surgery)
  • Gender(Baseline, pre-surgery)
  • Computed tomography (CT) scans(From enrollment to the end of follow-up at 2 weeks)
  • Japanese Orthopaedic Association (JOA) score(From enrollment to the end of follow-up at 1 year)
  • Medical comorbidity(Baseline, pre-surgery)
  • Previous spinal surgery(Baseline, pre-surgery)
  • Creatine kinase (CK)(From enrollment to the end of follow-up at 2 weeks)
  • VAS (visual analogue scale) for lower back pain(From enrollment to the end of follow-up at 1 year)
  • Postoperative hospital stays(Immediately after the discharge)
  • Body mass index (BMI)(Baseline, pre-surgery)
  • Smoking status(Baseline, pre-surgery)
  • Alcohol status(Baseline, pre-surgery)
  • Physical-component summary score of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)(From enrollment to the end of follow-up at 1 year)
  • Magnetic resonance imaging (MRI)(From enrollment to the follow-up at 2 weeks)
  • Modified MacNab criteria(From enrollment to the end of follow-up at 1 year)
  • Age(Baseline, pre-surgery)
  • Physical examination finding(Baseline, pre-surgery)
  • Affected level(Baseline, pre-surgery)
  • Symptoms duration(Baseline, pre-surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验